| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |